Recipharm Lifesciences India Private Limited, a amalgamated private limited company, was established on 01 February 2017 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2017PTC440046. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Suresh Nagappa Ganachari (Director), Emmanuel Nicolas Grand (Director), Daniela Schalko (Additional Director). Past directors included Lisa Maria Kristina Lundberg, Jean Francois Hilaire, Mark Quick Royston. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 502, B Wing, Building No. 48,, Tilak Indrayani Housing Society, Tilak Nagar (W), Chembur,, Mumbai, Maharashtra, 400089.
U51909MH2017PTC440046
440046
01 February 2017
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Recipharm Lifesciences India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Nagappa Ganachari | Director | 28 Nov 2022 | Current |
| Emmanuel Nicolas Grand | Director | 06 Jan 2023 | Current |
| Daniela Schalko | Additional Director | 28 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 15 Mar 2022 | Past |
| Pramod Abcsdd | Director | 30 Nov 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Recipharm Lifesciences India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Recipharm Lifesciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Recipharm Lifesciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recipharm Lifesciences India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Daniela Schalko was appointed as a Additional Director was appointed as a Additional Director on 28 Jan 2025 & has been associated with this company since 10 months 18 days . was completed.
Recipharm Lifesciences India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Recipharm Lifesciences India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Emmanuel Nicolas Grand was appointed as a Director was appointed as a Director on 06 Jan 2023 & has been associated with this company since 2 years 11 months . was completed.
The activity Suresh Nagappa Ganachari was appointed as a Director was appointed as a Director on 28 Nov 2022 & has been associated with this company since 3 years 19 days . was completed.
Recipharm Lifesciences India Private Limited was registered on 01 Feb 2017 with Roc Mumbai & aged 8 years 10 months as per MCA records. was recorded as a recent event.
When you finally get the last piece of the puzzle. #AcquisitionGoals #Recipharm #NitinLifesciences #SobtiFamily #BossMoves.
The CIN of Recipharm Lifesciences India Private Limited is U51909MH2017PTC440046.
Recipharm Lifesciences India Private Limited is headquartered at Flat No. 502, B Wing, Building No. 48,, Tilak Indrayani Housing Society, Tilak Nagar (W), Chembur,, Mumbai, Maharashtra, 400089.
Recipharm Lifesciences India Private Limited was incorporated on 01 February 2017.
The current directors of Recipharm Lifesciences India Private Limited are
The primary industry of Recipharm Lifesciences India Private Limited is Trade.
Recipharm Lifesciences India Private Limited is unlisted.
The authorized capital of Recipharm Lifesciences India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Recipharm Lifesciences India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX